✦ LIBER ✦

Cost-Effectiveness of Third-Line Anti-TNF Therapy Compared to Natalizumab in Patients With Moderate-to-Severe Crohn's Disease With Two Prior Anti-TNF Failures

✍ Scribed by Ananthakrishnan, Ashwin N. ;Hur, Chin ;Korzenik, Joshua R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1320 Natalizumab is Effective in the Tr

✍ Elvanides, Harry S.; Burchett, Mary; Ingram, Karen R.; Annis, Kim; Arsenescu, Ra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P.02.14 MAGNETIC RESONANCE ENTEROGRAPHY

✍ Annunziata, M.L.; Balestrieri, P.; Sansoni, I.; Coluccio, C.; Del Vescovo, R.; T 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

OC.11.5 ASSOCIATION OF THALIDOMIDE WITH

✍ Scribano, M.L.; Monterubbianesi, R.; Cantoro, L.; Kohn, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 94 KB

P458 Long-term efficacy and safety of ad

✍ Papamichael, K.; Archavlis, E.; Konstantopoulos, P.; Kyriakos, N.; Tsironikos, D 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Su2085 Association of Baseline C-Reactiv

✍ Sandborn, William J.; Colombel, Jean-Frederic; D'Haens, Geert R.; Robinson, Anne 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Individualised therapy is more cost-effe

✍ Steenholdt, Casper (author);Brynskov, Jørn (author);Thomsen, Ole Østergaard (aut 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 518 KB